Differential expression proteomics of human colon cancer

American Journal of Physiology - Gastrointestinal and Liver Physiology

Volumn 290, Issue 6, 2006, Pages

  Mazzanti, Roberto ^c   Solazzo, Michela ^c   Fantappié, Ornella ^c   Elfering, Sarah ^a   Pantaleo, Pietro ^c   Bechi, Paolo ^c   Cianchi, Fabio ^c   Ettl, Adam ^a   Giulivi, Cecilia ^b  

^a UNIVERSITY OF MINNESOTA DULUTH   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF FLORENCE   (Italy)

Author keywords

Apoptosis; Bioenergetics; Protein markers

Indexed keywords

MITOCHONDRIAL PROTEIN; POTASSIUM ION; SODIUM ION;

ADULT; AGED; ANAEROBIC GLYCOLYSIS; APOPTOSIS; ARTICLE; CARBOHYDRATE METABOLISM; CELL CYCLE; CLINICAL ARTICLE; COLON BIOPSY; COLON CANCER; COLORECTAL CANCER; CONTROLLED STUDY; ENERGY METABOLISM; FATTY ACID METABOLISM; FATTY ACID OXIDATION; FEMALE; HUMAN; HUMAN TISSUE; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEOMICS; SODIUM TRANSPORT; TIME OF FLIGHT MASS SPECTROMETRY; TWO DIMENSIONAL GEL ELECTROPHORESIS; WESTERN BLOTTING;

ADENOCARCINOMA; COLORECTAL NEOPLASMS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MIDDLE AGED; NEOPLASM PROTEINS; PROTEOME; REFERENCE VALUES; TUMOR MARKERS, BIOLOGICAL;

EID: 33646856626     PISSN: 01931857     EISSN: 15221547     Source Type: Journal    
DOI: 10.1152/ajpgi.00563.2005     Document Type: Article

References (83)

1. Anderson KM, Baranowski J, Olson L, and Economou SG. The distribution of acidic coomassie blue-stained proteins from uninvolved human liver, hepatoma, normal colon, primary colon cancer, and colon metastases to the liver, determined by 2D-protein electrophoresis. J Surg Oncol 24: 184-191, 1983.
2. Anderson L and Seilhamer J. A comparison of selected mRNA and protein abundances in human liver. Electrophoresis 18: 533-537, 1999.
3. Arakawa H, Hayashi N, Nagase H, Ogawa M, and Nakamura Y. Alternative splicing of the NF2 gene and its mutation analysis of breast and colorectal cancers. Hum Mol Genet 3: 565-568, 1994.
4. Ardavi MSM and Newsholme EA. Fuel utilization in colonocytes of the rat. Biochem J 231: 713-719, 1985.
5. Arnott D, O'Connell KL, King KL, and Stults JT. An integrated approach to proteome analysis: identification of proteins associated with cardiac hypertrophy. Anal Biochem 258: 1-18, 1998.
6. +-pump in solubilized tissue by the ouabain binding method coupled with high-performance gel chromatography. Biochim Biophys Acta 1240: 55-64, 1995.
7. Augenlicht LH, Anthony GM, Church TL, Edelmann W, Kucherlapati R, Yang K, Lipkin M, and Heerdt BG. Short-chain fatty acid metabolism, apoptosis, and Apc-initiated tumorigenesis in the mouse gastrointestinal mucosa. Cancer Res 59: 6005-6009, 1999.
8. Bass NM, Manning JA, Ockener RK, Gordon JI, Seetharam S, and Alpers DH. Regulation of the biosynthesis of two distinct fatty acid-binding proteins in rat liver and intestine. Influences of sex difference and of clofibrate. J Biol Chem 260: 1432-1436, 1985.
9. Bass NM. Function and regulation of hepatic and intestinal fatty acid binding proteins. Chem Phys Lipids 38: 95-114, 1985.
10. Basson MD, Liu YW, Hanly AM, Emenaker NJ, Shenoy SG, Gould M, and Rothberg BE. Identification and comparative analysis of human colonocyte short-chain fatty acid response genes. J Gastrointest Surg 4: 501-512, 2000.
11. Basson MD, Turowski GA, Rashid Z, Hong F, and Madri JA. Regulation of human colonic cell line proliferation and phenotype by sodium butyrate. Dig Dis Sci 41: 1989-1993, 1996.
12. Blottiere HM, Buecher B, Galmiche JP, and Cherbut C. Molecular analysis of the effect of short-chain fatty acids on intestinal cell proliferation. Proc Nutr Soc 62: 101-106, 2003.
13. +-pump in normal and pathological tissues. Mol Chem Neuropathol 19: 83-93, 1993.
14. Breckenridge DG, Nguyen M, Kuppig S, Reth M, and Shore GC. The procaspase-8 isoform, procaspase-8L, recruited to the BAP31 complex at the endoplasmic reticulum. Proc Natl Acad Sci USA 99: 4331-4336, 2002.
15. Buttgereit F and Brand MD. A hierarchy of ATP-consuming processes in mammalian cells. Biochem J 312: 163-167, 1995.
16. Carda-Abella P, Perez-Cuadrado S, Lara-Baruque S, Gil-Grande L, and Nunez-Puertas A. LDH isozyme patterns in tumors, polyps, and uninvolved mucosa of human cancerous colon. Cancer 49: 80-83, 1982.
17. Carroll SL, Roth KA, and Gordon JI. Liver fatty acid-binding protein: a marker for studying cellular differentiation in gut epithelial neoplasms. Gastroenterology 99: 1727-1735, 1990.
18. Celis JE, Ostergaard M, Basse B, Celis A, Lauridsen JB, Ratz GP, Andersen I, Hein B, Wolf H, Orntoft TF, and Rasmussen HH. Loss of adipocyte-type fatty acid binding protein and other protein biomarkers is associated with progression of human bladder transitional cell carcinomas. Cancer Res 56: 4782-4790, 1996.
19. Chapkin RS, Clark AE, Davidson LA, Schroeder F, Zoran DL, Lupton JR. Dietary fiber differentially alters cellular fatty acid-binding protein expression in exfoliated colonocytes during tumor development. Nutr Cancer 32: 107-112, 1998.
20. Chen P, Johnson P, Sommer T, Jentsch S, and Hochstrasser M. Multiple ubiquitin-conjugating-enzymes participate in the in vivo degradation of the yeast MAT alpha 2 repressor. Cell 74: 357-369, 1993.
21. Chen JS, Faller DV, and Spanjaard RA. Short-chain fatty acid inhibitors of histone deacetylases: promising anticancer therapeutics? Curr Cancer Drug Targets 3: 219-236, 2003.
22. Cianchi F, Cortesini C, Bechi P, Fantappie O, Messerini L, Vannacci A, Sardi I, Baroni G, Boddi V, Mazzanti R, and Masini E. Up-regulation of cyclooxygenase-2 gene expression correlates with tumor angiogenesis in human colorectal cancer. Gastroenterology 121: 1339-1347, 2001.
23. Cianchi F, Cortesini C, Fantappie O, Messerini L, Schiavone N, Vannacci A, Nistri S, Sardi I, Baroni G, Marzocca C, Perna F, Mazzanti R, Bechi P, and Masini E.. Inducible nitric oxide synthase expression in human colorectal cancer: correlation with tumor angiogenesis. Am J Pathol 162: 793-801, 2003.
24. Cole AR, Ji H, and Simpson RJ. Proteomic analysis of colonic crypts from normal, multiple intestinal neoplasia and p53-null mice: a comparison with colonic polyps. Electrophoresis 21: 1772-1781, 2000.
25. Corral M, Paris B, Baffet G, Tichonicky L, Guguen-Guillouzo C, Kruh J, and Defer N. Increased level of the mitochondrial ND5 transcript in chemically induced rat hepatomas. Exp Cell Res 184: 158-166, 1989.
26. Crambert G, Hasler U, Beggah AT, Yu C, Modyanov NN, Horisberger JD, Lelievre L, and Geering K. Transport and pharmacological properties of nine different human Na, K-ATPase isozymes. J Biol Chem 275: 1976-1986, 2000.
27. Cuezva JM, Krajewska M, de Heredia ML, Krajewski S, Santamaria G, Kim H, Zapata JM, Marusawa H, Chamorro M, and Reed JC. The bioenergetic signature of cancer: a marker of tumor progression. Cancer Res 62: 6674-6681, 2002.
28. Davis AF, Ropp PA, Clayton DA, and Copeland WC. Mitochondrial DNA polymerase gamma is expressed and translated in the absence of mitochondrial DNA maintenance and replication. Nucleic Acids Res 24: 2753-2759, 1996.
29. Dong X, Ghoshal K, Majumder S, Yadav SP, and Jacob ST. Mitochondrial transcription factor A and its downstream targets are up-regulated in a rat hepatoma. J Biol Chem 277: 43309-43318, 2002.
30. Duée PH, Darcy-Vrillon B, Blachier F, and Morel MT. Fuel selection in intestinal cells. Proc Nutr Soc 54: 84-94, 1995.
31. Elfering SL, Haynes V, Traaseth N, Ettl A, and Giulivi C. Aspects, mechanism, and biological relevance of mitochondrial protein nitration sustained by mitochondrial nitric oxide synthase. Am J Physiol Heart Circ Physiol 286: H22-H29, 2004.
32. Espineda C, Seligson DB, James Ball W Jr, Rao J, Palotie A, Horvath S, Huang Y, Shi T, and Rajasekaran AK. Analysis of the Na,K-ATPase alpha- and beta-subunit expression profiles of bladder cancer using tissue microarrays. Cancer 97: 1859-1868, 2003.
33. Fleming ID, Cooper JS, Henson DE, Hutler RVP, Kennedy BJ, Murphy GP, O'Sullivan B, Sobin LH, and Yarbro JW. Soft Tissue Sarcoma. American Joint Committee on Cancer Staging Manual. Philadelphia, PA: Lippincott-Raven, 1997, p. 149-156.
34. Gangl A and Ockner RK. Intestinal metabolism of plasma free fatty acids. Intracellular compartmentation and mechanisms of control. J Clin Invest 55: 803-813, 1975.
35. Glatz JFC and Veerkamp JH. Intracellular fatty acid-binding proteins. Int J Biochem 17: 13-22, 1985.
36. Gordon JI, Elshourbagy N, Lowe JB, Liao WS, Alpers DH, and Taylor JM. Tissue specific expression and developmental regulation of two genes coding for rat fatty acid binding proteins. J Biol Chem 260: 1995-1998, 1985.
37. Gordon JI, Smith DP, Alpers DH, and Strauss AW. Cloning of a complementary deoxyribonucleic acid encoding a portion of rat intestinal preapolipoprotein AIV messenger ribonucleic acid. Biochemistry 21: 5424-5431, 1982.
38. Gygi SP, Rochon Y, Franza BR, and Aebersold R. Correlation between protein and mRNA abundance in yeast. Mol Cell Biol 19: 1720-1730, 1999.
39. Hinnebusch BF, Meng S, Wu JT, Archer SY, and Hodin RA. The effects of short-chain fatty acids on human colon cancer cell phenotype are associated with histone hyperacetylation. J Nutr 132: 1012-1017, 2002.
40. Jan G, Belzacq AS, Haouzi D, Rouault A, Metivier D, Kroemer G, and Brenner C. Propionibacteria induce apoptosis of colorectal carcinoma cells via short-chain fatty acids acting on mitochondria. Cell Death Differ 9: 179-188, 2002.
41. Jellum E, Thorsrud AK, Vatn MH, Grimstad IA, Brennhovd I, Tveit KM, and Pihl A. Detection of cancer-related proteins by 2D-electrophoresis. Ann NY Acad Sci 428: 173-185, 1984.
42. Jentsch S. The ubiquitin-conjugation system. Annu Rev Genet 26: 179-207, 1992.
43. Ji H, Reid GE, Moritz RL, Eddes JS, Burgess AW, and Simpson RJ. A two-dimensional gel database of human colon carcinoma proteins. Electrophoresis 18: 605-613, 1997.
44. Keesee SK, Meneghini MD, Szaro RP, and Wu YJ. Nuclear matrix proteins in human colon cancer. Proc Natl Acad Sci USA 91: 1913-1916, 1994.
45. Larsson NG, Oldfors A, Holme E, and Clayton DA. Low levels of mitochondrial transcription factor A in mitochondrial DNA depletion. Biochem Biophys Res Commun 200: 1374-1381, 1994.
46. Lescale-Matys L, Hensley CB, Crnkovic-Markovic R, Putnam DS, and McDonough AA. Low K increases Na,K-ATPase abundance in LLC-PK1/Cl4 cells by differentially increasing beta, and not alpha, subunit mRNA. J Biol Chem 265: 17935-17940, 1990.
47. Mandal M, Olson DJ, Sharma T, Vadlamudi RK, and Kumar R. Butyric acid induces apoptosis by up-regulating Bax expression via stimulation of the c-Jun N-terminal kinase/activation protein-1 pathway in human colon cancer cells. Gastroenterology 120: 71-78, 2001.
48. Mani A and Gelmann EP. The ubiquitin-proteasome pathway and its role in cancer. J Clin Oncol 23: 4776-4789, 2005.
49. +-ATPase gene expression in normal rat kidney epithelial cells. Kidney Int 57: 1617-1635, 2000.
50. Nalty TJ, Taylor CW, and Yeoman LC. Variation in cytosolic protein expression between human colon tumors that differ with regard to differentiation class. Clin Chem 34: 71-75, 1988.
51. Ng FW, Nguyen M, Kwan T, Branton PE, Nicholson DW, Cromlish JA, and Shore GC. p28 Bap31, a Bcl-2/Bcl-XL- and procaspase-8-associated protein in the endoplasmic reticulum. J Cell Biol 139: 327-338, 1997.
52. Penta JS, Johnson FM, Wachsman JT, and Copeland WC. Mitochondrial DNA in human malignancy. Mutat Res 488: 119-133, 2001.
53. Rajasekaran SA, Ball WJ Jr, Bander NH, Liu H, Pardee JD, and Rajasekaran AK. Reduced expression of beta-subunit of Na,K-ATPase in human clear-cell renal cell carcinoma. J Urol 162: 574-580, 1999.
54. Rajasekaran SA, Palmer LG, Moon SY, Peralta Soler A, Apodaca GL, Harper JF, Zheng Y, and Rajasekaran AK. Na,K-ATPase activity is required for formation of tight junctions, desmosomes, and induction of polarity in epithelial cells. Mol Biol Cell 12: 3717-3732, 2001.
55. Rajasekaran SA, Palmer LG, Quan K, Harper JF, Ball WJ Jr, Bander NH, Peralta Soler A, and Rajasekaran AK. Na,K-ATPase beta-subunit is required for epithelial polarization, suppression of invasion, and cell motility. Mol Biol Cell 12: 279-295, 2001.
56. Ramaswamy S, Ross KN, Lander ES, and Golub TR. A molecular signature of metastasis in primary solid tumors. Nat Genet 33: 49-54, 2003.
57. Reymond MA, Sanchez JC, Schneider C, Rohwer P, Tortola S, Hohenberger W, Kirchner T, Hochstrasser DF, and Kockerling F. Specific sample preparation in colorectal cancer. Electrophoresis 18: 622-624, 1997.
58. Righetti PG, Castagna Herbert B A, Reymond F, and Rossier JS. Prefractionation techniques in proteome analysis. Proteomics 3: 1397-1407, 2003.
59. Righetti PG, Castagna A, Antonucci F, Piubelli C, Cecconi D, Campostrini N, Antonioli P, Astner H, and Hamdan M. Critical survey of quantitative proteomics in two-dimensional electrophoretic approaches. J Chromatogr A 1051: 3-17, 2004.
60. Roblick UJ, Hirschberg D, Habermann JK, Palmberg C, Becker S, Kruger S, Gustafsson M, Bruch HP, Franzen B, Ried T, Bergmann T, Auer G, and Jornvall H. Sequential proteome alterations during genesis and progression of colon cancer. Cell Mol Life Sci 61: 1246-1255, 2004.
61. Roediger WEW. Utilization of nutrients by isolated epithelial cells of the rat colon. Gastroenterology 83: 424-429, 1982.
62. Rossignol R, Gilkerson R, Aggeler R, Yamagata K, Remington SJ, and Capaldi RA. Energy substrate modulates mitochondrial structure and oxidative capacity in cancer cells. Cancer Res 64: 985-993, 2004.
63. +-ATPase alpha 3-isoform and down-regulation of the alpha1-isoform in human colorectal cancer. FEBS Lett 563: 151-154, 2004.
64. Sameni M, Dosescu J, Moin K, and Sloane BF. Functional imaging of proteolysis: stromal and inflammatory cells increase tumor proteolysis. Molecular Imaging 2: 159-175, 2003.
65. Sancho E, Vila MR, Sanchez-Pulido L, Lozano JJ, Paciucci R, Nadal M, Fox M, Harvey C, Bercovich B, Loukili N, Ciechanover A, Lin SL, Sanz F, Estivill X, Valencia A, and Thomson TM. Role of UEV-1, an inactive variant of the E2 ubiquitin-conjugating enzymes, in in vitro differentiation and cell cycle behavior of HT-29-M6 intestinal mucosecretory cells. Mol Cell Biol 18: 576-589, 1998.
66. Schmucker B, Tang Y, and Kressel M. Novel alternatively spliced isoforms of the neurofibromatosis type 2 tumor suppressor are targeted to the nucleus and cytoplasmic granules. Hum Mol Genet 8: 1561-1570, 1999.
67. Simpson RJ, Connolly LM, Eddes JS, Pereira JJ, Moritz RL, and Reid GE. Proteomic analysis of the human colon carcinoma cell line (LIM 1215): development of a membrane protein database. Electrophoresis 21: 1707-1732, 2000.
68. Stremmel W, Lotz G, Strohmeyer G, and Berk PD. Identification, isolation, and partial characterization of a fatty acid binding protein from rat jejunal microvillous membranes. J Clin Invest 75: 1068-1076, 1985.
69. Stulik J, Koupilova K, Osterreicher J, Knizek J, Macela A, Bures J, Jandik P, Langr F, Dedic K, and Jungblut PR. Protein abundance alterations in matched sets of macroscopically normal colon mucosa and colorectal carcinoma. Electrophoresis 20: 3638-3646, 1999.
70. Szymczyk P, Krajewska WM, Jakubik J, Berner A, Janczukowicz J, Mikulska U, Berner J, and Kilianska ZM. Molecular characterization of cellular proteins from colorectal tumors. Tumori 82: 376-381, 1996.
71. Taanman JW. The mitochondrial genome: structure, transcription, translation and replication. Biochim Biophys Acta 1410: 103-123, 1999.
72. Tilignac T, Temparis S, Combaret L, Taillandier D, Pouch MN, Cervek M, Cardenas DM, Le Bricon T, Debiton E, Samuels SE, Madelmont JC, and Attaix D. Chemotherapy inhibits skeletal muscle ubiquitin-proteasome-dependent proteolysis. Cancer Res 62: 2771-2777, 2002.
73. Tomasini R, Samir AA, Pebusque MJ, Calvo EL, Totaro S, Dagorn JC, Dusetti NJ, and Iovanna JL. p53-dependent expression of the stressinduced protein (SIP). Eur J Cell Biol 81: 294-301, 2002.
74. Tracy RP, Wold LE, Currie RM, and Young DS. Patterns for normal colon mucosa and colon adenocarcinoma compared by two-dimensional gel electrophoresis. Clin Chem 28: 915-919, 1982.
75. Vatn MH, Tjora S, Arva PH, Serck-Hanssen A, and Stromme JH. Enzymatic characteristics of tubular adenomas and carcinomas of the large intestine. Gut 23: 194-197, 1982.
76. Voss T and Haberl P. Observations on the reproducibility and matching efficiency of two-dimensional electrophoresis gels: consequences for comprehensive data analysis. Electrophoresis 21: 3345-3350, 2000.
77. Wachtershauser A and Stein J. Rationale for the luminal provision of butyrate in intestinal diseases. Eur J Nutr 39: 164-171, 2000.
78. Wang J and Friedman EA. Short-chain fatty acids induce cell cycle inhibitors in colonocytes. Gastroenterology 114: 940-946, 1998.
79. Warburg O. Experiments on surviving carcinoma tissues. Meth Biochem Z 142: 317-333, 1932.
80. White IR, Pickford R, Wood J, Skehel JM, Gangadharan B, and Cutler P. A statistical comparison of silver and SYPRO Ruby staining for proteomics analysis. Electrophoresis 25: 3048-3054, 2004.
81. +-adenosine triphosphatase gene expression by sodium ions in cultured neonatal rat cardiocytes. J Clin Invest 92: 1889-1895, 1993.
82. Zhang H, Li XJ, Martin DB, and Aebersold R. Identification and quantification of N-linked glycoproteins using hydrazide chemistry, stable isotope labeling and mass spectrometry. Nat Biotechnol 21: 660-666, 2003.
83. Zhang L, Zhou W, Velculescu VE, Kern SE, Hruban RH, Hamilton SR, Vogelstein B, and Kinzler KW. Gene expression profiles in normal and cancer cells. Science 276: 1268-1272, 1997.